Return to Cross Country Skiing and Other Physical Activities After Arthrodesis of the First Metatarsophalangeal Joint

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorOslo University Hospital

About this trial

Patients who have undergone arthrodesis of the first metatarsophalangeal joint due to hallux valgus or hallux rigidus are invited to participate in this study, which aims to investigate how the foot functions after this operation. Patients between 18 and 60 years of age at the time of surgery are eligible to participate. Questionnaires will be distributed to assess current sports function compared with function prior to surgery. Particular focus will be placed on function during cross-country skiing.

Eligibility criteria

Qualifiers

Patients who has underwent arthrodesis of the first metatarsofalangeal joint because of hallux rigidus or severe hallux valgus

Patients at age 18-60 at the date of surgery

At least one year follow-up, and maximum 5 years since surgery.

Disqualifiers

Non-Norwegian-speaking patients.

Impaired walking function.

Inability to cooperate.

Concomitant osteotomy of other metatarsals.

Trial design

Treatments tested in this trial

  • Arthrodesis

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Oslo University Hospital

Lead sponsor

Sorlandet Hospital HF

Collaborator